← Back to Search

Behavioural Intervention

RUBATO for Music

N/A
Recruiting
Research Sponsored by Rubato Life
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with Dementia, requiring reassessment every 3 months
Aged 18 or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial will study the effect of music-listening on dementia patients over 6-12 weeks. Patients in intervention group will listen to music with a smartwatch to measure heart rate variability.

Who is the study for?
This trial is for adults aged 18 or older with dementia who need check-ups every 3 months. They must have a smartphone, be able to use it (or have a caretaker who can), and possess a Google or Apple ID. It's not suitable for those with hearing issues not using aids, people who really dislike music, or anyone unable to commit to the app's minimum usage time.Check my eligibility
What is being tested?
The study tests the Rubato Life App by comparing two groups over 6-12 weeks: one uses the app daily for personalized music therapy while wearing smartwatches to track heart rate changes; the other receives standard care without this intervention.See study design
What are the potential side effects?
Since this trial involves listening to personalized music through an app, there are no direct medical side effects expected. However, participants may experience emotional responses or discomfort related to wearing smartwatches.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with dementia and need check-ups every 3 months.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety
Cognition
Depression
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: RUBATOExperimental Treatment1 Intervention
patients will be asked to listen (using headphones to accommodate patients with hearing aid) to a minimum of 30 minutes per day of music (or a total of 3.5 hours per week), coming up to their scheduled reassessment appointments (every 6 to 12 weeks) using the RL music selection application while wearing an individual smart bracelet aimed to build their optimal music therapy profile;
Group II: STANDARD OF CAREActive Control1 Intervention
patients will continue to receive standard of care.

Find a Location

Who is running the clinical trial?

Rubato LifeLead Sponsor
1 Previous Clinical Trials
200 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an ongoing effort to gather additional participants for this clinical trial?

"Affirmative. According to clinicaltrials.gov, this medical study is actively recruiting participants as of the date of this communication. The project was first launched on December 1st 2023 and last updated November 30th 2023; it requires a hundred individuals from one site to complete enrollment criteria."

Answered by AI

How many participants are joining the medical experiment?

"Affirmative. Clinicaltrials.gov data attests to the fact that this scientific examination is currently recruiting participants; it was first posted on December 1st 2023 and last modified on November 30th 2023, with an aim of enlisting 100 patients from a single site."

Answered by AI
~67 spots leftby Apr 2025